Your browser doesn't support javascript.
loading
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
Woods, Lucy A; Dolezal, Olan; Ren, Bin; Ryan, John H; Peat, Thomas S; Poulsen, Sally-Ann.
Affiliation
  • Woods LA; Griffith University , Eskitis Institute for Drug Discovery, Brisbane, Queensland Australia.
  • Dolezal O; CSIRO Biomedical Manufacturing Program, Melbourne, Victoria Australia.
  • Ren B; CSIRO Biomedical Manufacturing Program, Melbourne, Victoria Australia.
  • Ryan JH; CSIRO Biomedical Manufacturing Program, Melbourne, Victoria Australia.
  • Peat TS; CSIRO Biomedical Manufacturing Program, Melbourne, Victoria Australia.
  • Poulsen SA; Griffith University , Eskitis Institute for Drug Discovery, Brisbane, Queensland Australia.
J Med Chem ; 59(5): 2192-204, 2016 Mar 10.
Article in En | MEDLINE | ID: mdl-26882437

Full text: 1 Database: MEDLINE Main subject: Mass Spectrometry / Carbonic Anhydrase Inhibitors / Surface Plasmon Resonance / Carbonic Anhydrase II / Drug Evaluation, Preclinical / Small Molecule Libraries Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Language: En Journal: J Med Chem Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Mass Spectrometry / Carbonic Anhydrase Inhibitors / Surface Plasmon Resonance / Carbonic Anhydrase II / Drug Evaluation, Preclinical / Small Molecule Libraries Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Language: En Journal: J Med Chem Year: 2016 Type: Article